NHS ConfedExpo 2025: a platform for change in UK health and care
This year’s event took place on 11 to 12 June at Manchester Central
Read More
Author: Ella Day
Lumanity and Parker Institute partner to support delivery of new immunotherapies
The alliance combines Lumanity’s commercial and development strategy capabilities with PICI’s translational research expertise
Read More
Stephen Rayda
Worldwide Clinical Trials has appointed Stephen Rayda as Chief Digital and Information Officer
Read More
First treatment for common bladder cancer recommended by NICE
Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration
Read More
Lab-grown lung cancer cells show potential to revolutionise treatment
The model could lead to more targeted treatments for the disease
Read More- HSE approves new treatment for hidradenitis suppurativa and axial spondyloarthritis
- MSD to acquire Cidara after positive phase 2b trial results
- eXmoor Pharma and Royal Free London link to strengthen UK gene therapy
- Alzheimer’s prevention charity pioneers research on nutrition biomarkers to detect risk
- NICE recommends vutrisiran for adults with ATTR-CM in final draft guidance
